Medicine information EXJADE 500mg dispersible tablets
- Product code:
- W64442001
- Quantity:
- 28
- Indicated for:
- iron overload
- Route of administration:
- oral
- Substance:
- deferasirox (chelating agent)
- ATC
- V03AC03 — Various | All other therapeutic products | All other therapeutic products | Iron chelating agents
Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.
The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.
Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.
This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.
The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.
Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.
This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.
General data about EXJADE 500mg
- Substance:
- deferasirox
- Date of latest medicines list:
- 01-03-2022
- Product code:
- W64442001
- Strength:
- 500mg
- Pharmaceutical form:
- dispersible tablets
- Quantity:
- 28
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for deferasirox
Strengths available for deferasirox
- 125mg
- 180mg
- 250mg
- 360mg
- 500mg
- 90mg
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 20/08/2009
- Source record: last updated
- 05/02/2026